News Formal

These are the food and snack companies most at risk as the new obesity drugs revolutionize consumer behavior, according to BofA

  • 📰 CNBC
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 72%

Ireland News News

Ireland Ireland Latest News,Ireland Ireland Headlines

CNBC Pro compiled a few of the names the firm sees as at risk.

Food and snack companies may feel the most pressure as weight-loss drugs become more mainstream and impact consumer behaviors, according to Bank of America. Diabetes drugs that mimic gut hormones such as glucagon-like peptide-1, or GLP-1, have found new audiences in people looking to lose weight. In some instances, people taking these medicines have reported less of a hankering for unhealthy foods or alcohol and other drinks.

Pro compiled some of the stocks that could be at risk that the firm is watching. All data is from LSEG and current as of Friday morning: — 's Michael Bloom contributed to this report

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in İE
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Higher rates are killing the clean energy stocks—BofA says these are worth buyingBank of America is eyeing these renewable stocks to ride out turmoil in the sector.
Source: CNBC - 🏆 12. / 72 Read more »